Table 1.
• | Increase likelihood of truly negative surgical margins |
• | Increase likelihood of completion of all intended multimodality therapy |
• | Declaration of distant metastases and early progression of disease |
• | Declaration of patient’s functional status and inability to tolerate operation |
• | Opportunities for in vivo and in vitro testing for chemoresponsiveness |